Balance Sheet
Cash Flow Statement
AmortizationAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Depreciation & Amortization (CF) (2020 - 2025)

Historic Depreciation & Amortization (CF) for Legend Biotech (LEGN) over the last 6 years, with Q3 2025 value amounting to $2.1 million.

  • Legend Biotech's Depreciation & Amortization (CF) fell 986.98% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.5 million, marking a year-over-year decrease of 1148.55%. This contributed to the annual value of $10.7 million for FY2024, which is 3.74% down from last year.
  • Per Legend Biotech's latest filing, its Depreciation & Amortization (CF) stood at $2.1 million for Q3 2025, which was down 986.98% from $2.3 million recorded in Q2 2025.
  • Over the past 5 years, Legend Biotech's Depreciation & Amortization (CF) peaked at $3.2 million during Q1 2022, and registered a low of -$20000.0 during Q4 2021.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $2.7 million (2023), whereas its average is $2.4 million.
  • Data for Legend Biotech's Depreciation & Amortization (CF) shows a peak YoY increase of 1250500.0% (in 2022) and a maximum YoY decrease of 3892.57% (in 2022) over the last 5 years.
  • Over the past 5 years, Legend Biotech's Depreciation & Amortization (CF) (Quarter) stood at -$20000.0 in 2021, then soared by 12505.0% to $2.5 million in 2022, then grew by 9.88% to $2.7 million in 2023, then rose by 0.62% to $2.7 million in 2024, then fell by 21.76% to $2.1 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $2.1 million for Q3 2025, versus $2.3 million for Q2 2025 and $2.3 million for Q1 2025.